jasonschaffin
Well-known member
Now I know there are many people smarter than me out there that have probably already thought this out but does anyone think this is plausible? USP??
Invalid Link Removed=L-Dopa
Invalid Link Removed=Carbidopa
Carbidopa is similar to L-Dopa, obviously and the 1-C could be the methyl group (CH3) on the alpha (1) carbon of the carbonyl. Carbidopa can stop the decarboxylation of L-Dopa prolonging its halflife, it can not however cross the BBB. So it stops the conversion of L-Dopa peripherally but not in the brain I believe, prolonging the halflife and making sure more L-Dopa gets to cross the BBB. Thoughts....
Am I :fool2:
Invalid Link Removed=L-Dopa
Invalid Link Removed=Carbidopa
Carbidopa is similar to L-Dopa, obviously and the 1-C could be the methyl group (CH3) on the alpha (1) carbon of the carbonyl. Carbidopa can stop the decarboxylation of L-Dopa prolonging its halflife, it can not however cross the BBB. So it stops the conversion of L-Dopa peripherally but not in the brain I believe, prolonging the halflife and making sure more L-Dopa gets to cross the BBB. Thoughts....
Am I :fool2:
Last edited: